ENTRY       D11324                      Drug
NAME        Camidanlumab (USAN)
FORMULA     C6398H9946N1714O1992S42
EXACT_MASS  144005.7935
MOL_WEIGHT  144094.4484
SEQUENCE    (Heavy chain)
            QVQLVQSGAE VKKPGSSVKV SCKASGGTFS RYIINWVRQA PGQGLEWMGR IIPILGVENY
            AQKFQGRVTI TADKSTSTAY MELSSLRSED TAVYYCARKD WFDYWGQGTL VTVSSASTKG
            PSVFPLAPSS KSTSGGTAAL GCLVKDYFPE PVTVSWNSGA LTSGVHTFPA VLQSSGLYSL
            SSVVTVPSSS LGTQTYICNV NHKPSNTKVD KRVEPKSCDK THTCPPCPAP ELLGGPSVFL
            FPPKPKDTLM ISRTPEVTCV VVDVSHEDPE VKFNWYVDGV EVHNAKTKPR EEQYNSTYRV
            VSVLTVLHQD WLNGKEYKCK VSNKALPAPI EKTISKAKGQ PREPQVYTLP PSREEMTKNQ
            VSLTCLVKGF YPSDIAVEWE SNGQPENNYK TTPPVLDSDG SFFLYSKLTV DKSRWQQGNV
            FSCSVMHEAL HNHYTQKSLS LSPGK
            (Light chain)
            EIVLTQSPGT LSLSPGERAT LSCRASQSVS SYLAWYQQKP GQAPRLLIYG ASSRATGIPD
            RFSGSGSGTD FTLTISRLEP EDFAVYYCQQ YGSSPLTFGG GTKVEIKRTV AAPSVFIFPP
            SDEQLKSGTA SVVCLLNNFY PREAKVQWKV DNALQSGNSQ ESVTEQDSKD STYSLSSTLT
            LSKADYEKHK VYACEVTHQG LSSPVTKSFN RGEC
            (Disulfide bridge: H22-H96, H142-H198, H218-L-214, H224-H'224, H227-H'227, H259-H319, H365-H423, H'22-H'96, H'142-H'198, H'218-L'214, H'259-H'319, H'365-H'423, L23-L88 L134-L194, L'23-L'88, L'134-L'194)
  TYPE      Peptide
EFFICACY    Antineoplasitc, Anti-IL-2 receptor alpha antibody
  TYPE      Monoclonal antibody
COMMENT     Treatment of hematologic cancers
TARGET      IL2RA (CD25) [HSA:3559] [KO:K05068]
  PATHWAY   hsa04060(3559)  Cytokine-cytokine receptor interaction
            hsa04640(3559)  Hematopoietic cell lineage
BRITE       Target-based classification of drugs [BR:br08310]
             Cytokines and receptors
              Cytokine receptors
               Interleukin receptors
                IL2RA (CD25)
                 D11324  Camidanlumab (USAN)
DBLINKS     CAS: 921618-45-3
            PubChem: 384585302
///
